Please login to the form below

Not currently logged in

gene sequencing

This page shows the latest gene sequencing news and features for those working in and with pharma, biotech and healthcare.

UK trumpets life sciences post-Brexit ‘sector deal’

UK trumpets life sciences post-Brexit ‘sector deal’

GSK said the new cash will expand its commitment to the UK Biobank gene sequencing effort – allowing all 500, 000 genomes to be sequenced – and will strengthen its ‘open targets’collaboration

Latest news

More from news
Approximately 7 fully matching, plus 17 partially matching documents found.

Latest Intelligence

  • Under pressure Under pressure

    It is based on technologies, such as bioinformatics, gene sequencing, biomarkers and synthetic biology that make systems biology and systems medicine possible.

  • Harnessing complexity Harnessing complexity

    DNA changes can only be detected with sophisticated machinery that relies on advanced techniques such as real time polymerase chain reactions (PCR) and, increasingly, full gene sequencing. ... Next Generation Sequencing has been gradually increasing in

  • Pharma deals during February 2014 Pharma deals during February 2014

    In the meantime, Roche's pRED group will make use of Discuva's development technology, which uses gene sequencing and bioinformatics to identify targets for multi-drug resistant Gram-negative bacteria,

  • Pharma deals during September 2013 Pharma deals during September 2013

    Strengthening another of its business units, Roche's diagnostic arm announced a licensing deal with Pacific Bioscience for human in vitro diagnostic (IVD) gene sequencing technology, paying $35m upfront and additional ... Antisense technology is

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...